FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

13143001000001102: Co-prenozide 160mg/0.25mg modified-release tablets (product)


    Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 28-Nov 2018. Module: SNOMED CT United Kingdom drug extension module

    Descriptions:

    Id Description Lang Type Status Case? Module
    109561601000001117 Co-prenozide 160mg/0.25mg modified-release tablets (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
    109561701000001110 Co-prenozide 160mg/0.25mg modified-release tablets en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module


    0 descendants.

    Expanded Value Set


    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Co-prenozide 160mg/0.25mg modified-release tablets Is a Co-prenozide false Inferred relationship Existential restriction modifier
    Co-prenozide 160mg/0.25mg modified-release tablets Has active ingredient Oxprenolol false Inferred relationship Existential restriction modifier
    Co-prenozide 160mg/0.25mg modified-release tablets Has active ingredient Cyclopenthiazide false Inferred relationship Existential restriction modifier
    Co-prenozide 160mg/0.25mg modified-release tablets VMP prescribing status (attribute) VMP valid as a prescribable product false Inferred relationship Existential restriction modifier
    Co-prenozide 160mg/0.25mg modified-release tablets VMP non-availability indicator Not available false Inferred relationship Existential restriction modifier
    Co-prenozide 160mg/0.25mg modified-release tablets Has dispensed dose form Modified-release oral tablet false Inferred relationship Existential restriction modifier
    Co-prenozide 160mg/0.25mg modified-release tablets Has specific active ingredient Oxprenolol hydrochloride false Inferred relationship Existential restriction modifier
    Co-prenozide 160mg/0.25mg modified-release tablets Has specific active ingredient Cyclopenthiazide false Inferred relationship Existential restriction modifier
    Co-prenozide 160mg/0.25mg modified-release tablets Is a Virtual medicinal product false Inferred relationship Existential restriction modifier

    Inbound Relationships Type Active Source Characteristic Refinability Group
    Co-prenozide 160mg/0.25mg modified-release tablets 28 tablet Has VMP False Co-prenozide 160mg/0.25mg modified-release tablets Inferred relationship Existential restriction modifier
    Trasidrex modified-release tablets (Novartis Pharmaceuticals UK Ltd) Is a False Co-prenozide 160mg/0.25mg modified-release tablets Inferred relationship Existential restriction modifier

    This concept is not in any reference sets

    Back to Start